RB-101

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameRB-101
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitors
TargetsNeprilysin
Therapy Area/IndicationsDepressive Disorder, MajorSubstance-Related DisordersPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorSubstance-Related DisordersPain

Other Information

ATC CodeN/A
Related LinksN/A